NDC to RxNorm Crosswalk 0597-0430 Pradaxa

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 0597-0430 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Pradaxa . The unique RxCUI concepts linked to this product are: 2590616, 2590619, 2590620, 2590621, 2590623, 2590625, 2590627, 2590629, 2590631, 2590633, 2590635 and 2590637. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 2590616

Concept: dabigatran etexilate 110 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 110 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: dabigatran etexilate 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590619

Concept: Pradaxa 110 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 110 MG Oral Pellet [Pradaxa]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Pradaxa 110 MG Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590620

Concept: dabigatran etexilate 150 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 150 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: dabigatran etexilate 150 MG (as dabigatran etexilate mesylate 172.95 MG) Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590621

Concept: Pradaxa 150 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 150 MG Oral Pellet [Pradaxa]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Pradaxa 150 MG Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590623

Concept: dabigatran etexilate 20 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 20 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: dabigatran etexilate 20 MG (as dabigatran etexilate mesylate 23.06 MG) Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590625

Concept: Pradaxa 20 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 20 MG Oral Pellet [Pradaxa]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Pradaxa 20 MG Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590627

Concept: dabigatran etexilate 30 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 30 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: dabigatran etexilate 30 MG (as dabigatran etexilate mesylate 34.59 MG) Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590629

Concept: Pradaxa 30 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 30 MG Oral Pellet [Pradaxa]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Pradaxa 30 MG Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590631

Concept: dabigatran etexilate 40 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 40 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: dabigatran etexilate 40 MG (as dabigatran etexilate mesylate 46.12 MG) Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590633

Concept: Pradaxa 40 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 40 MG Oral Pellet [Pradaxa]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Pradaxa 40 MG Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590635

Concept: dabigatran etexilate 50 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 50 MG Oral Pellet: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

Concept: dabigatran etexilate 50 MG (as dabigatran etexilate mesylate 57.65 MG) Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 2590637

Concept: Pradaxa 50 MG Oral Pellet: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: dabigatran etexilate 50 MG Oral Pellet [Pradaxa]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Pradaxa 50 MG Oral Pellet: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.